Evaluating CNS Anti-inflammatory Therapies with Human Brain Organoids

Inflammatory pathways involving microglia, astrocytes, and cytokine signaling are widely implicated in disorders including Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, and traumatic brain injury. Yet despite significant investment in anti-inflammatory therapies, clinical success has remained limited. The post Evaluating CNS Anti-inflammatory Therapies with Human Brain Organoids appeared first on GEN - Genetic Engineering and Biotechnology News.